These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7545211

  • 1. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
    Le Cann P, Chabaud M, Leboulleux D, Mougin C, Mayelo V, Legrand MC, Calvet C, Afoutou JM, Coll-Seck AM, Coursaget P.
    J Med Virol; 1995 Apr; 45(4):410-4. PubMed ID: 7545211
    [Abstract] [Full Text] [Related]

  • 2. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
    Khanal S, Ferraris ED, Zahin M, Joh J, Ghim SJ, Jenson AB.
    Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
    [Abstract] [Full Text] [Related]

  • 3. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
    Kawana K, Kawana Y, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T.
    Vaccine; 2001 Jan 08; 19(11-12):1496-502. PubMed ID: 11163673
    [Abstract] [Full Text] [Related]

  • 4. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
    Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M.
    J Virol Methods; 2002 Oct 08; 106(1):61-70. PubMed ID: 12367730
    [Abstract] [Full Text] [Related]

  • 5. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):494-9. PubMed ID: 8133532
    [Abstract] [Full Text] [Related]

  • 6. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D, Rose RC, Williamson AL.
    J Med Virol; 1997 Feb 06; 51(2):126-31. PubMed ID: 9021543
    [Abstract] [Full Text] [Related]

  • 7. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y, Shah KV, Müller M, Muñoz N, Bosch XF, Viscidi RP.
    J Clin Microbiol; 1994 Sep 06; 32(9):2216-20. PubMed ID: 7529250
    [Abstract] [Full Text] [Related]

  • 8. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
    Kawana K, Matsumoto K, Yoshikawa H, Taketani Y, Kawana T, Yoshiike K, Kanda T.
    Virology; 1998 Jun 05; 245(2):353-9. PubMed ID: 9636375
    [Abstract] [Full Text] [Related]

  • 9. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
    Christensen ND, Dillner J, Eklund C, Carter JJ, Wipf GC, Reed CA, Cladel NM, Galloway DA.
    Virology; 1996 Sep 01; 223(1):174-84. PubMed ID: 8806551
    [Abstract] [Full Text] [Related]

  • 10. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K, Christensen ND, Höpfl R, Wartusch B, Zeimet A, Larcher C, Ruth N, Bergant A, Pirschner G, Dierich MP.
    Gynakol Geburtshilfliche Rundsch; 1995 Sep 01; 35 Suppl 1():25-31. PubMed ID: 8672922
    [Abstract] [Full Text] [Related]

  • 11. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P, Touze A, Enogat N, Leboulleux D, Mougin C, Legrand MC, Calvet C, Afoutou JM, Coursaget P.
    J Clin Microbiol; 1995 May 01; 33(5):1380-2. PubMed ID: 7615761
    [Abstract] [Full Text] [Related]

  • 12. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
    Kadish AS, Romney SL, Ledwidge R, Tindle R, Fernando GJ, Zee SY, Van Ranst MA, Burk RD.
    J Gen Virol; 1994 Sep 01; 75 ( Pt 9)():2277-84. PubMed ID: 8077925
    [Abstract] [Full Text] [Related]

  • 13. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL.
    J Virol; 2016 Jul 15; 90(14):6314-25. PubMed ID: 27147749
    [Abstract] [Full Text] [Related]

  • 14. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
    Cason J, Kambo PK, Best JM, McCance DJ.
    Int J Cancer; 1992 Feb 01; 50(3):349-55. PubMed ID: 1310487
    [Abstract] [Full Text] [Related]

  • 15. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
    Wikström A, Eklund C, Von Krogh G, Lidbrink P, Dillner J.
    J Clin Microbiol; 1992 Jul 01; 30(7):1795-800. PubMed ID: 1378454
    [Abstract] [Full Text] [Related]

  • 16. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K, Ishii Y, Ochi H, Matsumoto T, Yoshikawa H, Kanda T.
    Virology; 2007 Feb 20; 358(2):266-72. PubMed ID: 17010405
    [Abstract] [Full Text] [Related]

  • 17. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.
    Mund K, Han C, Daum R, Helfrich S, Müller M, Fisher SG, Schiller JT, Gissmann L.
    Intervirology; 1997 Feb 20; 40(4):232-7. PubMed ID: 9612724
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T.
    J Virol; 2001 Mar 20; 75(5):2331-6. PubMed ID: 11160736
    [Abstract] [Full Text] [Related]

  • 19. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S, Spagnoli G, Bulli L, Balz K, Yang F, Odenwald C, Seitz H, Mariz FC, Bolchi A, Ottonello S, Müller M.
    J Virol; 2018 Feb 15; 92(4):. PubMed ID: 29212932
    [Abstract] [Full Text] [Related]

  • 20. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
    Seitz H, Schmitt M, Böhmer G, Kopp-Schneider A, Müller M.
    Int J Cancer; 2013 Feb 01; 132(3):E139-48. PubMed ID: 22961598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.